Genmab — Juni 2024
-
Halozyme Announces Issuance of New European Patent for ENHANZE
Drug Delivery Platform https://markets.ft.com/data/announce/full?dockey=600-202406051605PR_NEWS_USPRX____LA32624-1 -
Tak for info omkring det nye europæiske patent.
-
HALO hæver guidance med $80 mln for 2024. Kan ikke lige gennemskue tallene. Men muligt at JNJ og Genmab skal dele den udgift. https://finance.yahoo.com/news/halozyme-raises-full-2024-financial-123000685.html
-
Celebrating 25 Years of Genmab! Today, we celebrated Genmab's 25th anniversary at their headquarters in Valby. Genmab’s CEO, Jan van de Winkel, opened the market together with employees, marking a… | Peter Legind-Hansen
Celebrating 25 Years of Genmab! Today, we celebrated Genmab's 25th anniversary at their headquarters in Valby. Genmab’s CEO, Jan van de Winkel, opened the market together with employees, marking a memorable moment for the company. We are proud to have Genmab among the strong listed companies on Nasdaq Copenhagen, contributing to Denmark's growth, innovation, and job creation. Nasdaq Copenhagen will continue to follow Genmab's success and innovation in the years to come🚀 Jan van de Winkel, Ph.D., Birgitte Stephensen, Marisol Mendez Peron, Solrun Sigfusdottir Øfjord, Carsten Borring, Sara Nolkrantz
LinkedIn (www.linkedin.com)
-
Godmorgen
-
@E L: ..smells like a new court case! xD
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind